دورية أكاديمية
Did the prevalence of depressive symptoms change during the COVID-19 pandemic? A multilevel analysis on longitudinal data from healthcare workers.
| العنوان: | Did the prevalence of depressive symptoms change during the COVID-19 pandemic? A multilevel analysis on longitudinal data from healthcare workers. |
|---|---|
| المؤلفون: | Hoffmann S; Department of Public Health, Brandenburg University of Technology Cottbus-Senftenberg, Germany.; Lausitz Center for Digital Public Health, Institute of Health, Brandenburg University of Technology Cottbus-Senftenberg, Germany., Schulze S; Faculty of Health Sciences Brandenburg, Joint Faculty of the University of Potsdam, Brandenburg University of Technology Cottbus-Senftenberg and Brandenburg Medical School, Germany.; Social and Preventive Medicine, Department of Sports and Health Sciences, Intra-faculty unit 'Cognitive Sciences', Faculty of Human Science, University of Potsdam, Germany.; Institute of Social Medicine and Epidemiology, Brandenburg Medical School Theodor Fontane, Germany., Löffler A; Department of Public Health, Brandenburg University of Technology Cottbus-Senftenberg, Germany., Becker J; Institute for Clinical Chemistry, Laboratory Diagnostics and Microbiology, Sana Kliniken Niederlausitz gGmbH, Senftenberg, Germany., Hufert F; Department of Microbiology and Virology, Medical University Brandenburg Theodor Fontane, Neuruppin, Germany., Gremmels HD; Institute for Clinical Chemistry, Laboratory Diagnostics and Microbiology, Sana Kliniken Niederlausitz gGmbH, Senftenberg, Germany., Holmberg C; Faculty of Health Sciences Brandenburg, Joint Faculty of the University of Potsdam, Brandenburg University of Technology Cottbus-Senftenberg and Brandenburg Medical School, Germany.; Institute of Social Medicine and Epidemiology, Brandenburg Medical School Theodor Fontane, Germany., Rapp MA; Faculty of Health Sciences Brandenburg, Joint Faculty of the University of Potsdam, Brandenburg University of Technology Cottbus-Senftenberg and Brandenburg Medical School, Germany.; Social and Preventive Medicine, Department of Sports and Health Sciences, Intra-faculty unit 'Cognitive Sciences', Faculty of Human Science, University of Potsdam, Germany., Entringer S; Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Medical Psychology, Germany.; Department of Pediatrics, and Development, Health and Disease Research Program University of California, Irvine, USA., Spallek J; Department of Public Health, Brandenburg University of Technology Cottbus-Senftenberg, Germany.; Lausitz Center for Digital Public Health, Institute of Health, Brandenburg University of Technology Cottbus-Senftenberg, Germany.; Faculty of Health Sciences Brandenburg, Joint Faculty of the University of Potsdam, Brandenburg University of Technology Cottbus-Senftenberg and Brandenburg Medical School, Germany. |
| المصدر: | The International journal of social psychiatry [Int J Soc Psychiatry] 2024 Feb; Vol. 70 (1), pp. 87-98. Date of Electronic Publication: 2023 Sep 06. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Sage Publications Country of Publication: England NLM ID: 0374726 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1741-2854 (Electronic) Linking ISSN: 00207640 NLM ISO Abbreviation: Int J Soc Psychiatry Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: <2002->: London : Sage Publications Original Publication: London Avenue Publishing Co |
| مواضيع طبية MeSH: | COVID-19*/epidemiology, Humans ; Depression/epidemiology ; Pandemics ; SARS-CoV-2 ; Cohort Studies ; Prevalence ; Multilevel Analysis ; Health Personnel/psychology |
| مستخلص: | Background: Healthcare workers (HCW) are at high risk to develop mental health problems during the COVID-19 pandemic because of additional work load, perceived stress, and exposure to patients with COVID-19. Currently, there are few studies on change over time in the prevalence of depressive symptoms during pandemic start among HCW. Thus, the aims of the current study were to examine whether depressive symptoms increased during the pandemic and were associated with perceived stress and own COVID-19 infection and workplace exposure to virus-infected patients. Methods: The cohort study used longitudinal data from HCW collected monthly (July 2020 till December 2020) during the first year of the pandemic before vaccination became available. The sample of n = 166 was drawn from a German hospital and included medical (e.g. nurses, therapists, and physicians) and administrative staff. Using multilevel models, we analyzed the change in depressive symptoms [assessed with General Depression Scale (GDS), a validated German version of the Center for Epidemiological Studies Depression Scale (CES-D)] and its association with perceived stress across the study period. Laboratory-confirmed own infection was tested as a potential moderator in this context. Subscales of the GDS were used to examine change over time of depressive symptom modalities (e.g. emotional, somatic, and social interactions (β, 95% confidence interval). Results: Depression scores increased significantly during the study period (β = .03, 95% CI [0.02, 0.05]). Perceived stress was associated with depressive symptoms (β = .12, 95% CI [0.10, 0.14]) but did not change over time. Exposure to COVID-19 infection was associated with a higher increase of depressive symptoms (β = .12, 95% CI [0.10, .14]). Somatic symptoms of depression increased among medical HCW with workplace exposure to COVID-19 (β = .25, 95% CI [0.13, 0.38]), but not in administrators (β = .03, 95% CI [-0.04, 0.11]). Conclusion: Research is needed to identify factors that promote the reduction of depressive symptoms in medical HCW with exposition to COVID-19 patients. Awareness of infection protection measures should be increased. Competing Interests: Conflict of interestThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. |
| References: | Am J Emerg Med. 2020 Sep;38(9):1727-1731. (PMID: 32738467) Asian J Psychiatr. 2020 Jun;51:102119. (PMID: 32339895) Lancet Psychiatry. 2020 Sep;7(9):813-824. (PMID: 32682460) Med Sci Monit. 2020 Apr 15;26:e924171. (PMID: 32291383) Psychiatry Res. 2020 Nov;293:113441. (PMID: 32898840) Front Psychol. 2021 May 21;12:663799. (PMID: 34093358) BMJ. 2022 Feb 16;376:e068993. (PMID: 35172971) Int J Environ Res Public Health. 2021 Oct 19;18(20):. (PMID: 34682743) Restor Dent Endod. 2017 May;42(2):152-155. (PMID: 28503482) J Affect Disord. 2022 Aug 15;311:40-46. (PMID: 35584726) World Psychiatry. 2015 Jun;14(2):231-3. (PMID: 26043341) BMC Public Health. 2021 Jan 9;21(1):104. (PMID: 33422039) Lancet Public Health. 2022 May;7(5):e406-e416. (PMID: 35298894) J Clin Psychol. 2006 Jan;62(1):123-46. (PMID: 16287149) Med Sci Monit. 2020 Mar 05;26:e923549. (PMID: 32132521) Brain Behav Immun. 2022 Mar;101:397-409. (PMID: 35131443) Arch Gen Psychiatry. 1961 Jun;4:561-71. (PMID: 13688369) Neurosci Biobehav Rev. 2021 Jul;126:252-264. (PMID: 33774085) JAMA Intern Med. 2020 Jun 1;180(6):817-818. (PMID: 32275292) JAMA. 2020 Apr 21;323(15):1439-1440. (PMID: 32163102) PLoS One. 2021 Feb 5;16(2):e0246602. (PMID: 33544761) Global Health. 2021 Mar 29;17(1):34. (PMID: 33781283) PLoS One. 2013;8(3):e58067. (PMID: 23469262) Epidemiology. 2018 Jan;29(1):87-95. (PMID: 28926372) J Health Soc Behav. 1983 Dec;24(4):385-96. (PMID: 6668417) J Health Monit. 2017 Oct 09;2(3):68-76. (PMID: 37168947) Biometrics. 1982 Dec;38(4):963-74. (PMID: 7168798) Int J Biol Macromol. 2022 Apr 15;204:161-168. (PMID: 35074332) BJPsych Open. 2023 Jun 22;9(4):e112. (PMID: 37345555) Behav Brain Res. 2021 Aug 27;412:113410. (PMID: 34116119) Psychon Bull Rev. 2004 Feb;11(1):192-6. (PMID: 15117008) Nat Rev Immunol. 2016 Jan;16(1):22-34. (PMID: 26711676) Psychiatry Res. 2020 Jun;288:112936. (PMID: 32276196) Brain Behav Immun. 2020 Oct;89:594-600. (PMID: 32738287) Psychother Psychosom. 2020;89(4):242-250. (PMID: 32272480) J Clin Nurs. 2023 Aug;32(15-16):5382-5395. (PMID: 33219569) Lancet. 2020 Mar 14;395(10227):912-920. (PMID: 32112714) JAMA Netw Open. 2020 Mar 2;3(3):e203976. (PMID: 32202646) J Health Monit. 2017 Oct 09;2(3):77-83. (PMID: 37168945) Front Psychol. 2021 Sep 21;12:703838. (PMID: 34621212) Mol Psychiatry. 2023 Jan;28(1):423-433. (PMID: 35668159) |
| فهرسة مساهمة: | Keywords: COVID-19; Depressive symptoms; healthcare workers; pandemic |
| تواريخ الأحداث: | Date Created: 20230906 Date Completed: 20240214 Latest Revision: 20240214 |
| رمز التحديث: | 20240214 |
| مُعرف محوري في PubMed: | PMC10860357 |
| DOI: | 10.1177/00207640231196737 |
| PMID: | 37671660 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1741-2854 |
|---|---|
| DOI: | 10.1177/00207640231196737 |